Angiodynamics Inc: Form 10-Q for the period ended Aug 31, 2014
Filed with the SEC on Oct 15, 2014 and accepted by EDGAR at Oct 15, 2014, 17:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-06-01 to 2014-08-31 | $87.3m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-06-01 to 2014-08-31 | $41.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-06-01 to 2014-08-31 | $45.8m | us-gaap:GrossProfit |
| Research and development | 3 months2014-06-01 to 2014-08-31 | $6.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2014-06-01 to 2014-08-31 | $3.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-06-01 to 2014-08-31 | $799.0k | us-gaap:InterestExpense |
| Income tax | 3 months2014-06-01 to 2014-08-31 | $948.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-06-01 to 2014-08-31 | $470.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-06-01 to 2014-08-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-06-01 to 2014-08-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-06-01 to 2014-08-31 | 35,885,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months2014-06-01 to 2014-08-31 | $5.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-08-31 | $13.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-08-31 | $154.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-08-31 | $796.1m | us-gaap:Assets |
| Current liabilities | At period end2014-08-31 | $63.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-08-31 | $256.4m | us-gaap:Liabilities |
| Current portion of debt | At period end2014-08-31 | $5.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-08-31 | $539.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001445305-14-004301. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.